Mersana Therapeutics Closes in on IPO After Announcing Expected Price Range
Mersana Therapeutics expects to price its 5 million shares in the range of $14 to $16 apiece in an initial public offering valued up to $92 million.
All Work
Chris Lange
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the U.S. broad markets with all the major indices posting a loss on the day. FANG stocks seemed to lead the charge down with Facebook, Alphabet, Amazon, and…
Is This the Death of Grocery Stores — All Over Again?
Kroger appears to be having its worst day, after reporting earnings. However, this is not the only stock suffering as a few other national chains are feeling the burn as well.
Why One Key Analyst Expects Little Growth From a Streamlined Nike
Nike has announced several operational and organizational changes in what it calls its Consumer Direct Offense. Perhaps the biggest highlight of this release was the 2% reduction in the global workforce.
What This Splunk Downgrade Really Means
Splunk saw its shares slide on Thursday after it caught a downgrade on the basis that it may be facing transition challenges.
More Trouble for Steel Stocks?
According to one key analyst, the weakness might be only pronounced in the short term but investors should be cautious around the Nucor and the steel industry.
Jabil Circuit Sinks Despite Beating Earnings
Shares of Jabil Circuit retreated Thursday despite a better-than-expected fiscal third-quarter financial report.
Why Canaccord Genuity Is Taking a Step Back on Alphabet
Canaccord Genuity still believes the FANG stock overall should reward investors, but the firm is taking a step back on Alphabet in particular.
Kroger Earnings Aren’t Enough to Balance Out Guidance
Kroger reported its fiscal first-quarter financial results and updated guidance before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday saw a mixed reaction in the broad markets with the S&P 500 and Nasdaq largely down offsetting Tuesdays gains, and the Dow remaining relatively flat. Crude oil was perhaps the biggest drag on…
Why Wedbush Sees Starbucks Slowing Down
Starbucks has made a decent run in 2017 so far, as the stock is up about 9% year to date, but one analyst thinks that Starbucks might slow down for the rest of the…
Why Credit Suisse Is Defending Micron
Micron Technology has its most recently quarterly earnings report scheduled for the end of June, but ahead of these results one key analyst decided to give its two cents on the DRAM giant.
Boston Omaha Closes in on IPO
Boston Omaha expects to price more than 5 million shares in the range of $12 to $14 apiece in an initial public offering valued up to more than $88 million.
Is Fiat Chrysler in Trouble After WVU Emissions Test Failures?
Fiat Chrysler Automobiles N.V. (NYSE: FCAU) was found to have some discrepancies in its emissions by West Virginia University researchers, up to 20-times the legal limit. The U.S. Department of Justice had previously alleged…
Aldeyra Stumbles Over Mid-Stage Clinical Results
Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial.
Alexion Pharmaceuticals Adds New CFO From Biogen
Shares of Alexion Pharmaceuticals saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a very strong day for the U.S. broad markets canceling out what was a sluggish Monday. There were green arrows practically everywhere with only a few exceptions, notably in telecom stocks. Seperately,…
How Omeros Won Big on This FDA Approval
Omeros saw its shares make a handy gain on Tuesday after the company announced that the FDA granted a Breakthrough Therapy designation for its treatment for IgA nephropathy.
Cheesecake Factory Serves Up Guidance Investors Can’t Stomach
After Cheesecake Factory gave an update for its second quarter outlook, the company is looking at its largest single-day loss since 2009.
Frontier Group Closes in on IPO
Frontier Group Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).